From: Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens
Reason
No. of Patients
Poor venous access
9
Severe headache or systemic reactions
7
Continuation after participation in the study
4
Personal preference
3
Others (thrombosis secondary to IGIV therapy)
1